Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fate Therapeutics (FATE) Return on Assets (2016 - 2025)

Fate Therapeutics' Return on Assets history spans 13 years, with the latest figure at 0.41% for Q4 2025.

  • For Q4 2025, Return on Assets changed 0.0% year-over-year to 0.41%; the TTM value through Dec 2025 reached 0.41%, changed 0.0%, while the annual FY2025 figure was 0.36%, 5.0% up from the prior year.
  • Return on Assets reached 0.41% in Q4 2025 per FATE's latest filing, up from 0.45% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.15% in Q2 2021 to a low of 0.46% in Q2 2025.
  • Average Return on Assets over 5 years is 0.34%, with a median of 0.36% recorded in 2024.
  • Peak YoY movement for Return on Assets: rose 19bps in 2021, then dropped -22bps in 2022.
  • A 5-year view of Return on Assets shows it stood at 0.23% in 2021, then crashed by -84bps to 0.42% in 2022, then increased by 21bps to 0.33% in 2023, then fell by -25bps to 0.41% in 2024, then grew by 0bps to 0.41% in 2025.
  • Per Business Quant, the three most recent readings for FATE's Return on Assets are 0.41% (Q4 2025), 0.45% (Q3 2025), and 0.46% (Q2 2025).